×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IOBT – io biotech, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IOBT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/12
11:33 am
iobt
IO Biotech, Inc. (NASDAQ: IOBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
IO Biotech, Inc. (NASDAQ: IOBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
11/12
07:12 am
iobt
IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights [Yahoo! Finance]
Medium
Report
IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights [Yahoo! Finance]
11/12
07:05 am
iobt
IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights
High
Report
IO Biotech Reports Third Quarter 2024 Financial Results and Provides Business Highlights
11/11
04:05 pm
iobt
IO Biotech Announces Participation in Upcoming Investor Conferences
High
Report
IO Biotech Announces Participation in Upcoming Investor Conferences
11/7
10:00 am
iobt
IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study
Low
Report
IO Biotech Reports its Off-the-Shelf Therapeutic Cancer Vaccine, IO102-IO103, in Combination with KEYTRUDA® Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Study
11/6
02:10 pm
iobt
IO Biotech, Inc. (NASDAQ: IOBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
IO Biotech, Inc. (NASDAQ: IOBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
11/3
09:25 am
iobt
Here's Why We're A Bit Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn Situation [Yahoo! Finance]
Neutral
Report
Here's Why We're A Bit Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn Situation [Yahoo! Finance]
10/4
09:00 am
iobt
IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
High
Report
IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/13
05:30 pm
iobt
Form SC 13G/A IO Biotech, Inc. Filed by: Stonepine Capital Management, LLC
Medium
Report
Form SC 13G/A IO Biotech, Inc. Filed by: Stonepine Capital Management, LLC
11/12
04:31 pm
iobt
Form 10-Q IO Biotech, Inc. For: Sep 30
Low
Report
Form 10-Q IO Biotech, Inc. For: Sep 30
11/12
09:22 am
iobt
Form 8-K IO Biotech, Inc. For: Nov 12
High
Report
Form 8-K IO Biotech, Inc. For: Nov 12
9/17
09:02 pm
iobt
Form SC 13D/A IO Biotech, Inc. Filed by: Novo Holdings A/S
Low
Report
Form SC 13D/A IO Biotech, Inc. Filed by: Novo Holdings A/S
9/11
09:05 pm
iobt
Form 144 IO Biotech, Inc. Filed by: Novo Holdings A/S
Medium
Report
Form 144 IO Biotech, Inc. Filed by: Novo Holdings A/S
8/30
04:11 pm
iobt
Form 8-K IO Biotech, Inc. For: Aug 30
High
Report
Form 8-K IO Biotech, Inc. For: Aug 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: